Sorry, you need to enable JavaScript to visit this website.
Skip to main content

Location Settings

Asia-Pacific

AU -  Sydney
AU -  Melbourne
AU -  Brisbane
CN -  Hong Kong
CN -  Shanghai
IN -  Bangalore
MY -  Kuala Lumpur
PH -  Metro Manila
CT -  Taipei City
CT -  Taipei City
TH -  Bangkok
NZ -  New Zealand
KR -  Seoul (Gangnam)
KR -  Gyeonggi-do
KR -  Seoul City Airport

North America

US -  Boston
US -  South Carolina

GLOBAL

English

CAREERS

SOLUTIONS

RESOURCES

ABOUT US

Location Settings

Asia-Pacific

AU -  Sydney
AU -  Melbourne
AU -  Brisbane
CN -  Hong Kong
CN -  Shanghai
IN -  Bangalore
MY -  Kuala Lumpur
PH -  Metro Manila
CT -  Taipei City
CT -  Taipei City
TH -  Bangkok
NZ -  New Zealand
KR -  Seoul (Gangnam)
KR -  Gyeonggi-do
KR -  Seoul City Airport

North America

US -  Boston
US -  South Carolina

GLOBAL

English

Novotech Acquires US CRO - Expands Global Expertise

Novotech Acquires US CRO - Expands Global Expertise

May 05,2022

Singapore and Charleston, SC - Novotech, the leading Asia-Pacific biotech specialist CRO, has acquired US CRO NCGS as part of a service expansion program for its global base of clients.

Novotech, which has a reputation for delivering full-service, high-quality expedited clinical trials in Asia-Pacific, can now offer its biotech clients clinical services in the US to support later phase global studies. 

NCGS, established in 1984 in South Carolina, is a privately held CRO with a biopharma client base.  NCGS has a workforce of about 300 professionals across the US.

Novotech CEO Dr. John Moller said “We are very pleased to acquire such an impressive company with a strong history of quality and delivery in the United States.. The company’s growth is a real credit to the knowledge and expertise of founder Nancy Snowden and the exceptional team she has formed”.

“This is a strategic move to provide US-based expertise and infrastructure for our US clients wanting trials in APAC and the US, and for our APAC clients wanting US clinical programs.” 

“Clients will receive seamless service, with a unified approach to systems and SOPs well developed” Moller said. 


Nancy C.G. Snowden, Founder and CEO of NCGS said the company was excited about being part of the Novotech operations globally and supporting Novotech’s clients  with their US clinical programs. We have a similar cultural fit and focus on excellence so joining Novotech will be seamless for our clients and Novotech’s clients. “Novotech and NCGS have a longstanding collaboration history of over a decade which will also support the seamless integration”, Snowden commented.

“NCGS focuses on complex areas of clinical development; oncology, hematology, infectious disease, and CNS in both adult and pediatric populations. 

Our lean organizational structure, nimble operational model with utilization of highly tenured staff have been specifically designed to overcome the challenges inhibiting our industry today. We have the ability to pivot in real time as the needs of the trial evolve.”

Novotech serves biotechs globally leveraging deep relationships built with hundreds of Asia-Pacific sites over the last 25 years.  NCGS compliments this with a broad US site base of hundreds of investigators with relationships spanning nearly four decades. 


Media Contact
David James
communications@novotech-cro.com
AU: +61 2 8218 2144 
USA: +1 415 951 3228
Asia: +65 3159 3427

About Novotech Health Holdings 
Novotech Health Holdings Pte. Ltd. (“Novotech”) is a leading Asia-Pacific biotech specialist CRO. Novotech Holdings is a CRO with integrated labs and phase I facilities providing drug development consulting and clinical development services. Novotech Holdings is well positioned to serve biopharmaceutical clients conducting clinical trials in Asia and globally. 

About NCGS
NCGS Incorporated, founded in 1984 is a full-service CRO that specializes in conducting and managing clinical trials. NCGS has supported the development of more than 70 approved pharma-biotech, diagnostic and device products with over 80 indications during its nearly four decades of operation.  

For more information visit https://novotech-cro.com/contact